These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37790551)

  • 1. Vaccination prevents IL-1β-mediated cognitive deficits after COVID-19.
    Vanderheiden A; Hill J; Jiang X; Deppen B; Bamunuarachchi G; Soudani N; Joshi A; Cain MD; Boon ACM; Klein RS
    Res Sq; 2023 Sep; ():. PubMed ID: 37790551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice.
    Vanderheiden A; Hill JD; Jiang X; Deppen B; Bamunuarachchi G; Soudani N; Joshi A; Cain MD; Boon ACM; Klein RS
    Nat Immunol; 2024 Jul; 25(7):1158-1171. PubMed ID: 38902519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain.
    Fernández-Castañeda A; Lu P; Geraghty AC; Song E; Lee MH; Wood J; Yalçın B; Taylor KR; Dutton S; Acosta-Alvarez L; Ni L; Contreras-Esquivel D; Gehlhausen JR; Klein J; Lucas C; Mao T; Silva J; Peña-Hernández MA; Tabachnikova A; Takahashi T; Tabacof L; Tosto-Mancuso J; Breyman E; Kontorovich A; McCarthy D; Quezado M; Hefti M; Perl D; Folkerth R; Putrino D; Nath A; Iwasaki A; Monje M
    bioRxiv; 2022 Jan; ():. PubMed ID: 35043113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death.
    Jeong GU; Lyu J; Kim KD; Chung YC; Yoon GY; Lee S; Hwang I; Shin WH; Ko J; Lee JY; Kwon YC
    Microbiol Spectr; 2022 Jun; 10(3):e0109122. PubMed ID: 35510852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis.
    Soung AL; Vanderheiden A; Nordvig AS; Sissoko CA; Canoll P; Mariani MB; Jiang X; Bricker T; Rosoklija GB; Arango V; Underwood M; Mann JJ; Dwork AJ; Goldman JE; Boon ACM; Boldrini M; Klein RS
    Brain; 2022 Dec; 145(12):4193-4201. PubMed ID: 36004663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis.
    Klein R; Soung A; Sissoko C; Nordvig A; Canoll P; Mariani M; Jiang X; Bricker T; Goldman J; Rosoklija G; Arango V; Underwood M; Mann JJ; Boon A; Dowrk A; Boldrini M
    Res Sq; 2021 Oct; ():. PubMed ID: 34729556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice.
    Fontes-Dantas FL; Fernandes GG; Gutman EG; De Lima EV; Antonio LS; Hammerle MB; Mota-Araujo HP; Colodeti LC; Araújo SMB; Froz GM; da Silva TN; Duarte LA; Salvio AL; Pires KL; Leon LAA; Vasconcelos CCF; Romão L; Savio LEB; Silva JL; da Costa R; Clarke JR; Da Poian AT; Alves-Leon SV; Passos GF; Figueiredo CP
    Cell Rep; 2023 Mar; 42(3):112189. PubMed ID: 36857178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice.
    Kim E; Khan MS; Ferrari A; Huang S; Sammartino JC; Percivalle E; Kenniston TW; Cassaniti I; Baldanti F; Gambotto A
    Microbiol Spectr; 2023 Jun; 11(3):e0436322. PubMed ID: 37162333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
    Boekel L; Stalman EW; Wieske L; Hooijberg F; van Dam KPJ; Besten YR; Kummer LYL; Steenhuis M; van Kempen ZLE; Killestein J; Volkers AG; Tas SW; van der Kooi AJ; Raaphorst J; Löwenberg M; Takkenberg RB; D'Haens GRAM; Spuls PI; Bekkenk MW; Musters AH; Post NF; Bosma AL; Hilhorst ML; Vegting Y; Bemelman FJ; Voskuyl AE; Broens B; Parra Sanchez A; van Els CACM; de Wit J; Rutgers A; de Leeuw K; Horváth B; Verschuuren JJGM; Ruiter AM; van Ouwerkerk L; van der Woude D; Allaart CF; Teng YKO; van Paassen P; Busch MH; Jallah PBP; Brusse E; van Doorn PA; Baars AE; Hijnen DJ; Schreurs CRG; van der Pol WL; Goedee HS; Vogelzang EH; Leeuw M; Atiqi S; van Vollenhoven R; Gerritsen M; van der Horst-Bruinsma IE; Lems WF; Nurmohamed MT; Boers M; Keijzer S; Keijser J; van de Sandt C; Boogaard A; Cristianawati O; Ten Brinke A; Verstegen NJM; Zwinderman KAH; van Ham SM; Rispens T; Kuijpers TW; Wolbink G; Eftimov F;
    Lancet Rheumatol; 2022 Jun; 4(6):e417-e429. PubMed ID: 35527808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complement-microglial axis drives synapse loss during virus-induced memory impairment.
    Vasek MJ; Garber C; Dorsey D; Durrant DM; Bollman B; Soung A; Yu J; Perez-Torres C; Frouin A; Wilton DK; Funk K; DeMasters BK; Jiang X; Bowen JR; Mennerick S; Robinson JK; Garbow JR; Tyler KL; Suthar MS; Schmidt RE; Stevens B; Klein RS
    Nature; 2016 Jun; 534(7608):538-43. PubMed ID: 27337340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.
    Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC;
    JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2.
    Thomas Κ; Grigoropoulos I; Alexopoulou P; Karofylakis E; Galani I; Papadopoulou KK; Tsiavou A; Ntourou A; Mavrou E; Qevani I; Katsimbri P; Koutsianas C; Mavrea E; Vassilopoulos D; Pournaras S; Tsiodras S; Boumpas D; Antoniadou A
    Rheumatology (Oxford); 2024 Feb; 63(2):534-541. PubMed ID: 37228039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs.
    Maurya R; Shamim U; Mishra P; Swaminathan A; Raina A; Tarai B; Budhiraja S; Pandey R
    Microbiol Spectr; 2023 Jun; 11(3):e0429222. PubMed ID: 37022180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
    Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
    J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients.
    Han A; Min S; Jo EA; Lee H; Kim YC; Han SS; Kang HG; Ahn YH; Oh I; Song EY; Ha J
    Ann Lab Med; 2024 Jan; 44(1):64-73. PubMed ID: 37665287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Anti-Spike IgG Antibody and ACE2 Receptor Binding Inhibition Levels among Breakthrough Stage Veteran Patients.
    Chensue SW; Siler AF; Kim PS; Dimcheff DE; Daghfal DJ; Prostko J; Frias E; Linder KA; Schildhouse RJ
    Microbiol Spectr; 2022 Dec; 10(6):e0274722. PubMed ID: 36409132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.